Genomic Analysis of Schizophrenia Reveals Altered Gene Expression in the Cerebellum
Author Information
Author(s): Mudge Joann, Miller Neil A., Khrebtukova Irina, Lindquist Ingrid E., May Gregory D., Huntley Jim J., Luo Shujun, Zhang Lu, van Velkinburgh Jennifer C., Farmer Andrew D., Lewis Sharon, Beavis William D., Schilkey Faye D., Virk Selene M., Black C. Forrest, Myers M. Kathy, Mader Lar C., Langley Ray J., Utsey John P., Kim Ryan W., Roberts Rosalinda C., Khalsa Sat Kirpal, Garcia Meredith, Ambriz-Griffith Victoria, Harlan Richard, Czika Wendy, Martin Stanton, Wolfinger Russell D., Perrone-Bizzozero Nora I., Schroth Gary P., Kingsmore Stephen F.
Primary Institution: National Center for Genome Resources
Hypothesis
The study aims to identify gene expression changes in the cerebellar cortex of schizophrenia patients compared to matched controls.
Conclusion
The study found significant differences in the expression of 215 genes between schizophrenia patients and controls, particularly those involved in synaptic vesicular transport and GABAergic neurotransmission.
Supporting Evidence
- 215 genes showed significant differences in expression between schizophrenia patients and controls.
- Genes involved in synaptic vesicular transport and GABAergic neurotransmission were particularly affected.
- Analysis included 16.7 billion nucleotides of sequencing data from post-mortem cerebellar cortices.
Takeaway
Researchers looked at brain samples from people with schizophrenia and found that many genes were expressed differently compared to people without the condition, which might help us understand the disease better.
Methodology
The study used shotgun mRNA sequencing to analyze gene expression in post-mortem cerebellar cortices from 14 schizophrenia patients and 6 matched controls.
Potential Biases
There may be biases due to the selection of cases and controls and the influence of medication on gene expression.
Limitations
The study is limited by the small sample size and the potential confounding effects of medication and cause of death.
Participant Demographics
All participants were male, with cases and controls matched for age, race, and cause of death.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website